Alirocumab (anti-PCSK9)
Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation.
Supplier | Selleck Chemicals |
---|---|
Product # | A2047 |
Sku # | A2047-1mg*25 |
Pricing | 1mg*25, $9870.00 |